These individuals may experience abrupt elevations in alanine aminotransferase (ALT) levels exceeding 1,000 U/L within 1–4 months of use, often accompanied by autoimmune hepatitis-like features. The gene discussed is GPT; the disease is autoimmune hepatitis.